An Advance Beneficiary Notice of Noncoverage, usually called an ABN, is a written heads-up that Medicare may not pay for a specific service you are about to receive. When you encounter one before a blood test, the lab or your doctor’s office is telling you that the test might be denied by Medicare, and if it is, you could be responsible for the bill. The form is a federal requirement, not a suggestion, and what you do with it has real financial consequences.
Why a Lab Hands You an ABN
Medicare does not cover every blood test a physician can order. Coverage depends on whether the test is considered “medically necessary” for your particular situation. That judgment is not left to your doctor alone. Medicare maintains lists of approved diagnoses and conditions that justify specific tests. These lists come in two forms: National Coverage Determinations, which apply everywhere, and Local Coverage Determinations, which vary by region. When your doctor orders a blood test and your diagnosis code does not match what those lists require, Medicare is likely to deny the claim.
A lab that submits a claim without a matching diagnosis code will have the payment denied. Under Medicare rules, the lab can only pass that cost on to you if it gave you an ABN before the blood was drawn and you signed it.
How the ABN Form Works
The ABN is not just a signature line. It presents you with a choice, typically three options, and which box you check determines what happens next.
- Option 1: You want the test performed, and you want the lab to submit the claim to Medicare anyway. If Medicare denies it, you agree to pay. This is the most common choice, because there is always a chance Medicare will cover it despite the warning.
- Option 2: You want the test performed, but you do not want the lab to bill Medicare at all. You agree to pay out of pocket from the start. People sometimes choose this when they know Medicare will deny the claim and do not want to wait for the denial before settling the bill.
- Option 3: You do not want the test performed. You walk away without owing anything for that particular test.
The form must also include an estimate of what the test will cost you. That number matters. A vague “you may owe something” is not enough. The ABN has to give you a reasonable dollar figure so you can make an informed decision before your blood is drawn, not after.
What Happens When a Provider Skips the ABN
If a lab or physician’s office fails to give you an ABN before performing a test that Medicare later denies, the provider absorbs the cost. You cannot be billed for it. This is not a courtesy; it is federal policy. The ABN serves as the legal mechanism that shifts financial responsibility from the provider to you, so without a properly completed and signed form, that shift never happens.
For the ABN to be valid, it must be signed and dated before the service is performed, not during the blood draw and not after results come back. A backdated form or one presented at the wrong time does not count. If you ever receive a bill for a Medicare-denied blood test and you are certain you never signed an ABN, you have grounds to dispute the charge.
Common Reasons Blood Tests Trigger an ABN
Certain blood tests come up against Medicare’s medical-necessity rules more often than others. Understanding the typical triggers helps you anticipate when an ABN might land in your lap.
Routine screening panels are a frequent source of confusion. Medicare covers some preventive screenings, like cholesterol checks and diabetes screening, but only at specific intervals and for patients who meet certain criteria. If your doctor orders the same lipid panel six months after your last one without a new clinical reason, Medicare may consider it medically unnecessary. The test itself is not the problem; the timing or the lack of a qualifying diagnosis is.
Vitamin D levels, thyroid panels, and testosterone testing are other common ABN triggers. These tests are covered when there is a documented medical reason, such as symptoms or a related condition, but Medicare frequently denies them when ordered as general wellness checks. When a service is ordered and the patient’s diagnosis is not approved under a Local or National Coverage Determination, or if the test is considered investigational, the physician or lab should obtain an ABN beforehand.
Genetic and specialized molecular tests are increasingly ordered but sit in a gray area for Medicare coverage. Newer tests sometimes lack a National Coverage Determination altogether, meaning there is no established rule saying Medicare will pay. In those cases, an ABN is the lab’s way of flagging that the claim is heading into uncertain territory.
The Difference Between Screening and Diagnostic Tests
One of the most confusing aspects of Medicare coverage for blood work is the distinction between a screening test and a diagnostic test. The same blood draw can be classified either way depending on why it was ordered, and that classification changes whether you might need an ABN.
A screening test is performed on someone with no symptoms, looking for early signs of disease. Medicare covers certain screenings at defined intervals: for example, a fasting glucose test for diabetes screening is covered once a year for people with specific risk factors. A diagnostic test is ordered because you already have symptoms or a known condition that your doctor is investigating or monitoring. Diagnostic tests are generally covered as long as the diagnosis code matches the coverage policy.
The trouble arises when a doctor orders a test that could be either. If your physician checks your blood sugar as part of a general checkup and you have no risk factors or symptoms, Medicare might classify it as a non-covered screening. If the same test is ordered because you have been experiencing fatigue and unexplained weight loss, it becomes a diagnostic test with a qualifying reason. The ABN exists for situations where the classification is ambiguous or where the screening does not meet Medicare’s specific eligibility rules.
You Can Ask About Costs Before the Blood Draw
Most patients never discuss the cost of a blood test before it happens. Research published in JAMA found that while roughly two-thirds of patients wanted to talk with their doctor about out-of-pocket costs, only about 15 percent of patients had ever actually had that conversation. Physicians were more likely to recognize when a patient was financially burdened if a prior cost discussion had taken place, but those discussions rarely happened unprompted.
If you receive an ABN, treat it as an opening to ask questions. You can ask the lab or your doctor’s office how much the test costs if Medicare denies it, whether a different test might accomplish the same clinical goal with a covered diagnosis code, or whether the test can wait until your next covered screening interval. You are not being difficult by asking. The ABN is literally designed to give you a moment to make a financial decision, and you should use it.
It also helps to ask whether the ordering physician can provide additional clinical documentation that might support medical necessity. Sometimes the issue is not that the test is inappropriate but that the diagnosis code on the order does not fully reflect your medical history. A more specific code, one that reflects a symptom or condition you actually have, can sometimes turn a denial into an approval.
What If You Have Private Insurance Instead of Medicare
ABNs are a Medicare-specific form. If you have commercial health insurance through an employer or the marketplace, your insurer does not use the ABN. However, private insurers have their own versions. These are commonly called financial responsibility waivers or non-covered service agreements. They serve the same basic purpose: informing you that a service may not be covered and asking you to accept responsibility for the bill if the claim is denied.
The key difference is regulatory. Medicare ABNs are governed by federal rules with specific requirements for format, timing, and content. Commercial insurance waivers are contractual, meaning they are governed by the terms of your insurance policy and state law rather than a single federal standard. The protections vary by insurer and by state, so you may have more or fewer rights depending on your plan.
If you have private insurance and a lab asks you to sign a waiver before a blood test, the same general advice applies: read the form, ask what the test will cost if denied, and consider whether the test is essential right now. The difference is that you cannot rely on the same federal protections that apply to Medicare ABNs, such as the rule that an invalid or missing ABN means the provider eats the cost.
How Much Blood Tests Cost Without Coverage
One reason the ABN matters is that lab test prices are wildly inconsistent. If Medicare denies a claim and you are on the hook, the amount you owe depends on the lab, your location, and the specific test. A basic metabolic panel might cost anywhere from $10 to over $100 at different facilities. Specialized tests like genetic panels or certain hormone assays can run into the hundreds or even thousands of dollars.
Hospital-based labs tend to charge more than independent labs for the same test. Research examining hospital pricing transparency found that cash prices were on average 60 percent higher than negotiated insurance prices, and list prices (the sticker price before any discount) were on average 164 percent higher than what insurers actually paid. The spread between the cheapest and most expensive hospitals for the same procedure was enormous, with price ratios ranging from roughly 6-to-1 up to 30-to-1 depending on the service and the type of price being compared.
If you sign an ABN and Medicare denies the test, the price you owe is typically the lab’s charge amount, not a negotiated rate. Some labs offer a cash-pay or self-pay discount, but you usually have to ask for it. Before signing an ABN, it is worth knowing whether the lab where your blood will be drawn is a hospital outpatient lab or an independent reference lab, because that distinction alone can change your bill substantially.
Disputing a Bill After Signing an ABN
Signing an ABN does not mean you have no recourse. If you chose Option 1, meaning you wanted the test and wanted the lab to submit the claim, Medicare will process the claim and issue a formal coverage decision. If the claim is denied, you receive a Medicare Summary Notice explaining the reason. You have the right to appeal that denial.
The appeals process has multiple levels. The first step is a redetermination, which is essentially asking Medicare to take another look. If that fails, you can request a reconsideration by a Qualified Independent Contractor, which is a separate entity from the one that made the original decision. Most patients do not pursue appeals for small lab charges, but for expensive tests, the process is there and has no filing fee.
Where patients sometimes get confused is thinking that the ABN itself is the bill. It is not. The ABN is a pre-service notification. The bill comes later, and only if Medicare actually denies the claim. If you sign an ABN and Medicare ends up covering the test after all, you owe nothing beyond your normal deductible and coinsurance. The ABN only activates financially when the denial it warned you about actually happens.
When an ABN Is Not Required
Not every potential denial triggers an ABN. Medicare distinguishes between services that are never covered and services that might not be covered for a specific patient. ABNs are required only for the second category. If a service is categorically excluded from Medicare benefits, such as cosmetic procedures or certain experimental treatments, the provider does not need to issue an ABN because the service was never a Medicare benefit in the first place. A different notice, called a Notice of Exclusion from Medicare Benefits, applies in those situations.
ABNs also do not apply to emergency services. If you are in an emergency department and blood work is drawn as part of urgent care, the lab is not expected to pause and present you with coverage paperwork. The ABN process is designed for planned, non-emergency services where there is time to have the conversation and make a choice.
Similarly, if your doctor orders a blood test and has every reason to believe Medicare will cover it based on your diagnosis, no ABN is needed. The form is specifically for situations where the provider has reason to expect a denial. A provider who routinely hands ABNs to every patient for every test is arguably misusing the form, because the ABN is meant to flag specific, foreseeable coverage gaps rather than serve as a blanket liability shield.
ABNs and Repeat or Monitoring Blood Work
Patients with chronic conditions often need the same blood tests repeated at regular intervals. If you take a medication that requires liver function monitoring every three months, Medicare generally covers those tests because the monitoring is medically necessary. But coverage rules sometimes cap the frequency. If your doctor wants to check levels monthly instead of quarterly, the additional draws may exceed what Medicare considers necessary, and the lab should give you an ABN for the extra tests.
This is particularly common with warfarin (blood thinner) monitoring, diabetes management, and thyroid medication adjustments. The clinical need for more frequent testing is real, but Medicare’s coverage frequency limits are based on population-level guidelines, not your individual case. Your doctor may have a good medical reason for checking more often, but unless the documentation supports it through a specific diagnosis or clinical change, the claim can still be denied.
If you find yourself getting ABNs repeatedly for the same monitoring test, it is worth asking your doctor to add a note to the order explaining why more frequent testing is needed. Sometimes the difference between coverage and denial is a line in the medical record that says “dosage adjustment in progress” or “unstable levels requiring closer monitoring.” That clinical context can be the difference between Medicare paying and you paying.